Bavarian Nordic says first milestone payment under J&J deal could be in 2019
COPENHAGEN (Reuters) – Danish biotech company Bavarian Nordic expects to get its first milestone payment under a deal with Janssen Pharmaceuticals in 2019, if clinical trials for vaccines targeting hepatitis B and HIV-1 get underway next year, a company executive said.
Bavarian Nordic last month signed a deal with Janssen, a unit of Johnson & Johnson, with a potential value of up to $879 million including upfront, equity investment and milestone payments.
The company will produce clinical material for HIV and hepatitis within the next six to nine months, and Janssen aims to begin clinical trials during 2018.
“I think that if the studies get underway next year, the first milestone payment could happen in 2019,” Bavarian’s Chief Financial Officer Ole Larsen told Reuters on Friday.
The company in June posted positive data from a phase 2 study of a universal vaccine against respiratory syncytial virus (RSV) – a common cause of bronchiolitis and pneumonia.
Larsen said that with the potential for such a vaccine the company would need to find a commercial partner for that as well.
Still, depending on how the rest of the pipeline develops, Bavarian may begin to develop its own sales force for respiratory diseases in certain smaller regions such as the Nordic countries, Larsen said.
The company expects to begin phase 3 clinical trials for RSV in the autumn of 2019, he said.
The company’s shares have risen about 65 percent this year.
The next big trigger could be results of a phase 3 trial for prostate cancer drug Prostvac, which according to Larsen are expected in November or December.
The company earlier posted second quarter revenue of 397.3 million Danish crowns and maintained its financial expectations for the year.
Reporting by Jacob Gronholt-Pedersen, editing by David Evans and Elaine Hardcastle
Source link
#USA #News #USnews #worldnews #headlinenews #Breakingnews #weathernews #UnitedStates news #CanadianNews #weatherforecast top news #stories, #hourlyweather #Reuters
Related News
Leafs beat Habs 6-0 with two goals from Matthews
Bill Beacon, The Canadian Press Published Saturday, November 18, 2017 11:37PM EST MONTREAL – Ron Read More
Battered GE shares lure some buyers but worst may not be over
NEW YORK (Reuters) – General Electric Co shares stabilized after a brutal slide last week Read More